Correlation Between Stoke Therapeutics and Vincerx Pharma
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Vincerx Pharma, you can compare the effects of market volatilities on Stoke Therapeutics and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Vincerx Pharma.
Diversification Opportunities for Stoke Therapeutics and Vincerx Pharma
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Stoke and Vincerx is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Vincerx Pharma go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Vincerx Pharma
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 0.7 times more return on investment than Vincerx Pharma. However, Stoke Therapeutics is 1.42 times less risky than Vincerx Pharma. It trades about 0.03 of its potential returns per unit of risk. Vincerx Pharma is currently generating about 0.0 per unit of risk. If you would invest 1,269 in Stoke Therapeutics on August 31, 2024 and sell it today you would lose (58.00) from holding Stoke Therapeutics or give up 4.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Vincerx Pharma
Performance |
| Timeline |
| Stoke Therapeutics |
| Vincerx Pharma |
Stoke Therapeutics and Vincerx Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Vincerx Pharma
The main advantage of trading using opposite Stoke Therapeutics and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Vincerx Pharma vs. Cue Biopharma | Vincerx Pharma vs. Eliem Therapeutics | Vincerx Pharma vs. Inhibrx | Vincerx Pharma vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |